Literature DB >> 7649749

Longitudinal patterns of medical service use and costs among people with AIDS.

J A Fleishmann1, V Mor, L L Laliberte.   

Abstract

OBJECTIVE: This study examines the effect of race, HIV transmission group, and decedent status on the use and cost of inpatient and outpatient care among people with AIDS. DATA SOURCES: Data come from 914 people with AIDS who were receiving services in nine cities across the United States in 1990-1991 and who indicated that a hospital clinic was their usual source of care. Review of hospital medical and billing records provided data on use and costs of medical services over an 18-month period. Vital status was determined from hospital records and death certificates. STUDY
DESIGN: Data from each respondent were aggregated into three-month intervals, beginning with the last quarter of data and working backward. Regression analyses using random-effect models and generalized estimating equations were conducted to assess temporal patterns of inpatient and outpatient use and costs. PRINCIPAL
FINDINGS: Inpatient utilization and costs were higher for decedents than for nondecedents. However, differences between decedents and nondecedents varied as a function of race. Nonwhites had more inpatient use and higher costs than whites, but lower outpatient use, and these differences were greater among decedents. Inpatient nights and costs rose sharply in the six months prior to death. Outpatient use and costs did not display as strong a temporal trend.
CONCLUSIONS: Much of the cost of treating HIV infection is concentrated in the period immediately preceding death. The intensity of service use in the terminal period should be considered when developing estimates of annual costs of care and when designing programs to provide community-based treatment.

Entities:  

Mesh:

Year:  1995        PMID: 7649749      PMCID: PMC2495094     

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  24 in total

1.  Case-managing AIDS.

Authors:  P S Jellinek
Journal:  Issues Sci Technol       Date:  1988       Impact factor: 1.255

2.  The 'Medicaidization' of AIDS. Trends in the financing of HIV-related medical care.

Authors:  J Green; P S Arno
Journal:  JAMA       Date:  1990-09-12       Impact factor: 56.272

3.  Models for longitudinal data: a generalized estimating equation approach.

Authors:  S L Zeger; K Y Liang; P S Albert
Journal:  Biometrics       Date:  1988-12       Impact factor: 2.571

Review 4.  Long-term care and AIDS: perspectives from experience with the elderly.

Authors:  A E Benjamin
Journal:  Milbank Q       Date:  1988       Impact factor: 4.911

5.  Zidovudine and the natural history of the acquired immunodeficiency syndrome.

Authors:  R D Moore; J Hidalgo; B W Sugland; R E Chaisson
Journal:  N Engl J Med       Date:  1991-05-16       Impact factor: 91.245

6.  Medical care costs of patients with AIDS in San Francisco.

Authors:  A A Scitovsky; M Cline; P R Lee
Journal:  JAMA       Date:  1986-12-12       Impact factor: 56.272

7.  Utilization and charges for terminal cancer patients in Rhode Island.

Authors:  W D Spector; V Mor
Journal:  Inquiry       Date:  1984       Impact factor: 1.730

8.  The costs of AIDS in Los Angeles.

Authors:  C L Bennett; M Cvitanic; A Pascal
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

9.  AIDS treatment costs during the last months of life: evidence from the ACSUS.

Authors:  F J Hellinger; J A Fleishman; D C Hsia
Journal:  Health Serv Res       Date:  1994-12       Impact factor: 3.402

10.  Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons.

Authors:  M D Stein; J Piette; V Mor; T J Wachtel; J Fleishman; K H Mayer; C C Carpenter
Journal:  J Gen Intern Med       Date:  1991 Jan-Feb       Impact factor: 5.128

View more
  8 in total

1.  Hospital care for persons with AIDS in European-Union countries; a cross-country comparison.

Authors:  M J Postma; H Kornarou; V Paparizos; R M Leidl; K Tolley; J Kyriopoulos; J C Jager
Journal:  Health Care Manag Sci       Date:  2000-01

2.  Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study.

Authors:  R Andersen; S Bozzette; M Shapiro; P St Clair; S Morton; S Crystal; D Goldman; N Wenger; A Gifford; A Leibowitz; S Asch; S Berry; T Nakazono; K Heslin; W Cunningham
Journal:  Health Serv Res       Date:  2000-06       Impact factor: 3.402

Review 3.  The cost of HIV treatment and care. A global review.

Authors:  E J Beck; A H Miners; K Tolley
Journal:  Pharmacoeconomics       Date:  2001-01       Impact factor: 4.981

4.  Economic analysis of initial HIV treatment. Efavirenz- versus indinavir-containing triple therapy.

Authors:  J J Caro; J A O'Brien; K Migliaccio-Walle; G Raggio
Journal:  Pharmacoeconomics       Date:  2001-01       Impact factor: 4.981

5.  Incidence and duration of hospitalizations among persons with AIDS: an event history approach.

Authors:  S Crystal; A T Lo Sasso; U Sambamoorthi
Journal:  Health Serv Res       Date:  1999-02       Impact factor: 3.402

6.  Social and medical factors affecting hospital discharge of persons with HIV/AIDS.

Authors:  K A Bonuck; P S Arno
Journal:  J Community Health       Date:  1997-08

7.  Home-care use and expenditures among Medicaid beneficiaries with AIDS.

Authors:  U Sambamoorthi; S R Collins; S Crystal; J Walkup
Journal:  Health Care Financ Rev       Date:  1999

8.  Inpatient, Outpatient, and Pharmacy Costs in Patients With and Without HIV in the US Veteran's Affairs Administration System.

Authors:  Scott Sutton; Joseph Magagnoli; Tammy Cummings; James Hardin; Babatunde Edun
Journal:  J Int Assoc Provid AIDS Care       Date:  2019 Jan-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.